Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders

Author： Buzard Daniel J   Thatte Jayant   Lerner Michael   Edwards Jeffrey   Jones Robert M  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.18, Iss.10, 2008-10, pp. : 1141-1159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Development of Agonists Selective for &bgr;1-Type Thyroid Hormone Receptor

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 1, 2007-01 ,pp. : 79-86

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Development of Selective TRPV1 Antagonists for Pain

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 16, 2008-11 ,pp. : 1431-1441

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid CB1 and CB2 Receptor Ligand Specificity and the Development of CB2-Selective Agonists

By  

Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. : 1428-1443

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Development of Subtype Selective Nicotinic Acetylcholine Receptor Ligands

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 4, 2002-08 ,pp. : 337-348

Bentham Science Publishers

Access to resources Recommend Favorite

Recent developments in ghrelin receptor (GHS-R1a) agonists and antagonists

By Carpino Philip A  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. : 1599-1618

Informa Healthcare

Access to resources Recommend Favorite